Use of Entresto (Sacubitril/Valsartan) for the Treatment of Peripheral Arterial Disease
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Cenderitide (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- 21 Apr 2017 Status changed from not yet recruiting to recruiting.
- 20 Dec 2016 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 20 Dec 2016 Planned primary completion date changed from 1 Feb 2018 to 1 May 2018.